These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 29272095)
1. Hyaluronic Acid-Shelled Disulfide-Cross-Linked Nanopolymersomes for Ultrahigh-Efficiency Reactive Encapsulation and CD44-Targeted Delivery of Mertansine Toxin. Zhang Y; Wu K; Sun H; Zhang J; Yuan J; Zhong Z ACS Appl Mater Interfaces; 2018 Jan; 10(2):1597-1604. PubMed ID: 29272095 [TBL] [Abstract][Full Text] [Related]
2. Glutathione-Sensitive Hyaluronic Acid-SS-Mertansine Prodrug with a High Drug Content: Facile Synthesis and Targeted Breast Tumor Therapy. Zhong P; Zhang J; Deng C; Cheng R; Meng F; Zhong Z Biomacromolecules; 2016 Nov; 17(11):3602-3608. PubMed ID: 27723970 [TBL] [Abstract][Full Text] [Related]
3. Reduction-responsive core-crosslinked hyaluronic acid-b-poly(trimethylene carbonate-co-dithiolane trimethylene carbonate) micelles: synthesis and CD44-mediated potent delivery of docetaxel to triple negative breast tumor in vivo. Zhu Y; Zhang J; Meng F; Cheng L; Feijen J; Zhong Z J Mater Chem B; 2018 May; 6(19):3040-3047. PubMed ID: 32254339 [TBL] [Abstract][Full Text] [Related]
4. A Smart Nano-Prodrug Platform with Reactive Drug Loading, Superb Stability, and Fast Responsive Drug Release for Targeted Cancer Therapy. Meng H; Zou Y; Zhong P; Meng F; Zhang J; Cheng R; Zhong Z Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28464449 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma. Gu Z; Wang X; Cheng R; Cheng L; Zhong Z Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
7. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel. Wang X; Cheng R; Zhong Z Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162 [TBL] [Abstract][Full Text] [Related]
8. α Zhong P; Gu X; Cheng R; Deng C; Meng F; Zhong Z Int J Nanomedicine; 2017; 12():7913-7921. PubMed ID: 29138558 [TBL] [Abstract][Full Text] [Related]
9. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
10. α Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551 [TBL] [Abstract][Full Text] [Related]
11. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake. Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864 [TBL] [Abstract][Full Text] [Related]
12. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093 [TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223 [TBL] [Abstract][Full Text] [Related]
14. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials. Sun B; Deng C; Meng F; Zhang J; Zhong Z Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338 [TBL] [Abstract][Full Text] [Related]
15. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice. Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045 [TBL] [Abstract][Full Text] [Related]
16. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles. Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871 [TBL] [Abstract][Full Text] [Related]
17. Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia. Qiu J; Cheng R; Zhang J; Sun H; Deng C; Meng F; Zhong Z Biomacromolecules; 2017 Oct; 18(10):3207-3214. PubMed ID: 28835099 [TBL] [Abstract][Full Text] [Related]
18. Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers. Yue S; Zhang Y; Wei Y; Haag R; Sun H; Zhong Z Biomacromolecules; 2022 Jan; 23(1):100-111. PubMed ID: 34913340 [TBL] [Abstract][Full Text] [Related]
19. An intelligent cell-selective polymersome-DM1 nanotoxin toward triple negative breast cancer. Zhang Y; Yue S; Haag R; Sun H; Zhong Z J Control Release; 2021 Dec; 340():331-341. PubMed ID: 34774889 [TBL] [Abstract][Full Text] [Related]
20. cRGD-installed docetaxel-loaded mertansine prodrug micelles: redox-triggered ratiometric dual drug release and targeted synergistic treatment of B16F10 melanoma. Zhong P; Qiu M; Zhang J; Sun H; Cheng R; Deng C; Meng F; Zhong Z Nanotechnology; 2017 Jul; 28(29):295103. PubMed ID: 28574851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]